Amr Hassan

21.4k total citations
54 papers, 498 citations indexed

About

Amr Hassan is a scholar working on Pathology and Forensic Medicine, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Amr Hassan has authored 54 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 11 papers in Neurology and 10 papers in Psychiatry and Mental health. Recurrent topics in Amr Hassan's work include Multiple Sclerosis Research Studies (17 papers), Peripheral Neuropathies and Disorders (6 papers) and Migraine and Headache Studies (6 papers). Amr Hassan is often cited by papers focused on Multiple Sclerosis Research Studies (17 papers), Peripheral Neuropathies and Disorders (6 papers) and Migraine and Headache Studies (6 papers). Amr Hassan collaborates with scholars based in Egypt, United Kingdom and United States. Amr Hassan's co-authors include Mohamed Hegazy, Nirmeen A. Kishk, Hatem Shehata, Akmal El‐Mazny, Amr El-Nemr, Maged Abdel Naseer, Mona Hussein, Nevin Shalaby, Alaa Elmazny and Hassan Mostafa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Construction and Building Materials.

In The Last Decade

Amr Hassan

47 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amr Hassan Egypt 14 128 101 66 61 59 54 498
Yüksel Terzi Türkiye 13 43 0.3× 96 1.0× 54 0.8× 63 1.0× 85 1.4× 38 728
Eun Soo Kim South Korea 15 39 0.3× 87 0.9× 64 1.0× 25 0.4× 39 0.7× 63 575
Yahya Çelik Türkiye 17 117 0.9× 170 1.7× 213 3.2× 18 0.3× 149 2.5× 44 638
G. Romano Italy 14 25 0.2× 120 1.2× 79 1.2× 106 1.7× 44 0.7× 57 624
Erkan Kozanoğlu Türkiye 10 98 0.8× 80 0.8× 18 0.3× 21 0.3× 89 1.5× 37 561
Gürsel Acartürk Türkiye 13 38 0.3× 140 1.4× 33 0.5× 21 0.3× 20 0.3× 35 686
D Klaus Austria 9 192 1.5× 52 0.5× 18 0.3× 21 0.3× 40 0.7× 20 444
Remzi Doğan Türkiye 15 29 0.2× 65 0.6× 58 0.9× 20 0.3× 15 0.3× 121 833
Yimin Chen China 14 24 0.2× 249 2.5× 82 1.2× 5 0.1× 17 0.3× 78 557
Xiang Ding China 14 70 0.5× 36 0.4× 29 0.4× 17 0.3× 37 0.6× 35 601

Countries citing papers authored by Amr Hassan

Since Specialization
Citations

This map shows the geographic impact of Amr Hassan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amr Hassan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amr Hassan more than expected).

Fields of papers citing papers by Amr Hassan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amr Hassan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amr Hassan. The network helps show where Amr Hassan may publish in the future.

Co-authorship network of co-authors of Amr Hassan

This figure shows the co-authorship network connecting the top 25 collaborators of Amr Hassan. A scholar is included among the top collaborators of Amr Hassan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amr Hassan. Amr Hassan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hassan, Amr, et al.. (2025). Noonan Syndrome and Osteoporosis: A Comprehensive Case Study and Literature Review. 1(1). 1–4. 1 indexed citations
2.
Hassan, Amr, et al.. (2025). Bond behavior of steel reinforcement in alkali-activated slag concrete exposed to ambient and elevated temperatures. Case Studies in Construction Materials. 23. e05559–e05559.
3.
Kishk, Nirmeen A., Reham Shamloul, Rehab Magdy, et al.. (2024). Epilepsy Arabic renaming to cerebroelectric disorder could minimize the stigma. Epilepsy Research. 210. 107495–107495.
4.
Hassan, Amr, et al.. (2024). The significance of miRNA-191-5P and miRNA-24-3P as novel biomarkers for multiple sclerosis: a case–control study. SHILAP Revista de lepidopterología. 25(1). 1 indexed citations
5.
6.
Hussein, Mona, et al.. (2024). Reliability, validity, and responsiveness of the Arabic version of HIT ‐6 questionnaire in patients with migraine indicated for preventive therapy: A multi‐center study. Headache The Journal of Head and Face Pain. 64(5). 500–508. 2 indexed citations
7.
Hassan, Amr, et al.. (2023). Effect of hybrid polypropylene fibers on mechanical and shrinkage behavior of alkali-activated slag concrete. Construction and Building Materials. 411. 134485–134485. 41 indexed citations
8.
9.
10.
Hussein, Mona, et al.. (2021). Physical and Mental Fatigue in Subjects Recovered from COVID-19 Infection: A Case–Control Study. Neuropsychiatric Disease and Treatment. Volume 17. 2063–2071. 12 indexed citations
11.
Hassan, Amr, et al.. (2021). Co-Occurrence of Guillain-Barre Syndrome and Multiple Sclerosis: A Rare Case Report. SHILAP Revista de lepidopterología. 4(1). 31–35. 2 indexed citations
12.
Shaker, Olfat, et al.. (2021). MicroRNA-22 Level in Patients with Multiple Sclerosis and Its Relationship with Vitamin D and Vitamin D Receptor Levels. NeuroImmunoModulation. 29(2). 128–134. 2 indexed citations
13.
Langdon, Dawn, Nevin Shalaby, Hatem Shehata, et al.. (2021). Reliability and validity of Arabic version of the brief international cognitive assessment for multiple sclerosis: Egyptian dialect. The Egyptian Journal of Neurology Psychiatry and Neurosurgery. 57(1). 19 indexed citations
14.
Hamdy, Sherif, Maged Abdel Naseer, Hatem Shehata, et al.. (2020). <p>Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach</p>. Therapeutics and Clinical Risk Management. Volume 16. 651–662. 11 indexed citations
15.
16.
Hamdy, Sherif, Maged Abdel Naseer, Hatem Shehata, et al.. (2020). <p>Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era</p>. Therapeutics and Clinical Risk Management. Volume 16. 759–767. 3 indexed citations
17.
Kishk, Nirmeen A., et al.. (2019). <p>Evaluating optic nerve diameter as a possible biomarker for disability in patients with multiple sclerosis</p>. Neuropsychiatric Disease and Treatment. Volume 15. 2571–2578. 10 indexed citations
18.
Naseer, Maged Abdel, et al.. (2019). Glutamate and Nitric Oxide as biomarkers for disease activity in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 38. 101873–101873. 19 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yüksel Terzi Breakdown of academic impact, for papers by Eun Soo Kim Breakdown of academic impact, for papers by Yahya Çelik Breakdown of academic impact, for papers by G. Romano Breakdown of academic impact, for papers by Erkan Kozanoğlu Breakdown of academic impact, for papers by Gürsel Acartürk Breakdown of academic impact, for papers by D Klaus Breakdown of academic impact, for papers by Remzi Doğan Breakdown of academic impact, for papers by Yimin Chen Breakdown of academic impact, for papers by Xiang Ding
Rankless by CCL
2026